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Although the study of vertebrate ovarian function has emphasized on the 
regulation by pituitary gonadotropins, lines of evidence have substantiated the 
presence and importance of intraovarian paracrine or autocrine factors which 
mediate the cross-talk between the oocyte and the follicular layer. The reproductive 
role of epidermal growth factor (EGF) family ligands were well characterized in 
higher vertebrates and they were considered to be the downstream mediators of 
gonadotropins in regulating key ovarian functions such as oocyte maturation and 
steroidogenesis. However, the production site of the EGF family within the follicle 
still remains controversial due to the discrepancy between different studies. 
Besides, little information about the paracrine regulation of the ovarian EGF family 
is available. Therefore, the present study was undertaken to investigate the 
spatiotemporal distribution and paracrine and autocrine regulation of EGF family in 
ovary using zebrafish as model. 
RT-PCR analysis demonstrated that the EGF family ligands transforming 
growth factor a (tgfa), betacellulin (btc) and heparin-binding EGF-like growth 
factor (hbegf) expressed universally in almost all zebrafish tissues including the 
gonads while egf expressed predominantly in the gonads. Within the follicle, the 
EGF family ligands expressed exclusively in the oocyte except btc whose expression 
could be detected in both oocyte and follicle layer but with a much higher 
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expression in the oocyte. In contrast, the common receptor of these ligands, namely 
EGF receptor (egfr), was expressed exclusively in the follicle layer. This strongly 
implicated a potential role of the EGF family ligands as oocyte-derived factors to 
regulate the function of follicular layer in zebrafish ovarian follicle. The expression 
level of egfr increased significantly during folliculogenesis in parallel to those of 
gonadotropin receptors. Besides, the absence of egfr expression during early 
embryonic development further supports the involvement of the EGF family in 
folliculogenesis instead of embryogenesis. 
All four of the EGF family ligands were expressed in cultured follicle cells 
despite the lack of expression of egf, tgfa and hbegf in freshly isolated follicle 
layers. Treatment of the cultured follicle cells with EGF, BTC and HB-EGF 
demonstrated a differential auto-regulation of the ligands. Whereas the expression 
of htc was consistently down-regulated by the ligands, hbegf increased its 
expression in response to the ligands. These suggested the presence of EGF 
signaling network in the zebrafish ovary and the expressions of the intrafollicular 
EGF system is possibly fine-tuned by itself. Furthermore, the EGF ligands were 
also effective in stimulating the expression of subunits of activin, another important 
intraovarian local factor, activin Pa (inhba) and Pb (inhbb) in cultured follicle cells. 
Considering the exclusive expression of inhba and inhbb in the follicular layer and 
predominant expression of activin receptors in the oocyte, we hypothesize that there 
is a regulatory loop between the oocyte and follicular layer mediated by EGF 
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Considering producing offspring as the ultimate destination of every 
individual, it is not surprising to find every single step of reproduction being so 
immensely regulated and coordinated. Compared to males, female reproduction is 
more intricate and more appealing to scientists owing to its cyclic nature. 
The follicle, being the functional unit of the female reproductive organ 
ovary, consists of the female gamete oocyte and the surrounding somatic follicular 
cells including the granulosa cells and theca cells. Therefore, the development of 
the follicle or folliculogenesis not only denotes the development of the oocyte, but 
also the cellular changes of the granulosa and theca cells in the follicular layer (1, 2). 
1.1.1 In Mammals 
After the mitotic proliferative phase in fetal or neonatal stage, the oogonia 
cease dividing and enter meiosis where they arrest in the dictyate first meiotic 
prophase and form the primordial follicles (3). After puberty, the primordial 
follicles start to be periodically recruited to commence folliculogenesis. 
Folliculogenesis is tightly regulated by the pituitary gonadotropins, follicle 
stimulating hormone (FSH) and luteinizing hormone (LH), as well as ovarian steroid 
hormones, particularly estradiol-17(3 (E2) (1). The biosynthesis and secretion of E2 
involve both gonadotropins and the two follicle cells in that LH promotes the 
synthesis of androgens in the theca cells while FSH induces their aromatization to 
estrogens in the granulosa cells (the "two-cell, two-gonadotropins" model) (4). 
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In mammals, the early development of the follicles is marked by the 
increase in oocyte diameter and follicular cell proliferation, which advance the 
s 
primordial follicles to the preantral stage (1, 2). It is well established that FSH but 
not LH plays a main role in stimulating the preantral follicle growth and granulosa 
cell proliferation (5). Later, estradiol and FSH synergistically trigger the formation 
of follicular antrum, which marks the beginning of the antral phase of development 
(6). The follicle afterward has a complex organization and is named Graafian 
follicle. In the Graafian follicle, the oocyte is surrounded by a layer of cumulus 
granulosa cells, which is suspended in the follicular fluid while connected to the rim 
of mural granulosa cells by a stalk of cells. The theca cell layer is also separated 
into the highly vascular theca interna and the fibrous theca externa (1, 2). 
Afterward, the dominant antral follicle enters the preovulatory phase with its growth 
and steroidogenic activity sustained by LH (7). Resumption of meiosis is then 
evoked by the surge of LH and the oocyte undergoes a series of profound changes 
including germinal vesicle breakdown (GVBD) to become mature for fertilization 
(2). Thereupon the LH-stimulated progesterone induces prostaglandin production 
which in turn causes follicle rupture and results in oocyte expulsion from the follicle 
at ovulation (8). 
1.1.2 In Teleosts 
In contrast to mammals, the teleost follicle has no antrum so that most of 
the volume is occupied by the oocyte. An acellular zona radiata separates the oocyte 
and the monolayer of granulosa cells (9). However, communication is still possible 
between the oocyte and granulosa cells due to the presence of microvilli which run 
across the radial canal of the zona radiata and link the two compartments by gap 
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junctions (10). Like the case in mammals, on top of the granulosa layer is the basal 
lamina followed by the vascularized theca layer. 
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As a result of the diverse aquatic environments, teleosts have adopted a 
variety of different reproductive strategies. With respect to the stages of follicle 
development in the ovary, four main patterns of folliculogenesis are found in fish, 
namely, synchronous, group-synchronous, multiple-batch group-synchronous and 
asynchronous (11). Undoubtedly this difference brings about the discrepancy in 
follicular regulation or function among fish species and thus may be the reason for 
the inconsistency of experimental results often reported in the literature when 
different fish models are used. 
1.1.2.1 Vitellogenesis 
Without lactation and placentation in fish, the most striking difference 
between folliculogenesis of mammals and teleosts is the need of vitellogenesis in the 
latter (12). Vitellogenesis is the character of oviparous vertebrates in which the 
hepatic precursor vitellogenin is transported via the blood stream to the ovary and 
taken up by the growing oocytes. In the oocyte, vitellogenin is catalyzed by 
cathepsin D (13) to become two major yolk proteins, lipovitellin and phosvitin (14), 
to serve as nutrient reserves for embryonic development. 
It is generally accepted that gonadotropins act on the theca cells to 
stimulate the production of androgen which diffuses to the granulosa cells and is 
converted to E2 by P450 aromatase (P450arom) (15). The synthesized E2 then 
travels in the blood to the liver to trigger vitellogenin production there. The kind of 
gonadotropin involved in this process seems to be species specific since FSH and 
LH were shown to stimulate E2 production in salmonids (16) and red seabream (17) 
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respectively. Moreover, FSH also plays a part in mediating the uptake of 
vitellogenin into the oocyte (18). 
1.1.2.2 Oocyte Maturation 
The onset of germinal vesicle migration to a peripheral position is usually 
considered as the early sign of oocyte maturation. Subsequently, GVBD comes 
about indicating the resumption of the first meiotic division (15). Reorganization of 
lipoproteic yolk (13) and water entry (19) effectuates yolk clarification and oocyte 
volume increase, respectively, the two features not observable in mammals. 
In species like rainbow trout, the plasma LH level starts to go up when 
vitellogenesis is accomplished, suggesting its role in stimulating final oocyte 
maturation (20). It has also been demonstrated that the homologous LH but not FSH 
induces oocyte maturation in seabream (21). Maturation-inducing hormone (MIH) 
has been isolated in many teleost species as the candidate to mediate LH action on 
oocyte maturation. In most teleost species investigated, 17a, 20p-dihydroxy-4-
pregnen-3-one (DHP) has been identified as the MIH (22, 23) while in some species 
it is 17a, 20P, 21 -trihydroxy-4-pregnen-3-one (20(3-8) (24). A two-cell model 
resembling the production of E2 by follicular cells has been proposed for DHP 
production in fish ovarian follicles (25). According to this model, 17a-
hydroxyprogesterone is produced by the theca cells and diffuses to the granulosa 
cells in which it is converted to DHP by the enzyme 20(3-hydroxysteroid 
dehydrogenase (20P-HSD). DHP then binds to its membrane receptor on the oocyte 
to inhibit adenylate cyclase activity (26). The decline in oocyte cAMP levels 
activates the cytoplasmic maturation-promoting factor (MPF), comprising cdc2 
kinase and cyclin B, to trigger meiotic resumption (25, 27). 
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LH regulates the process of maturation in two stages (28). In the first 
stage, it enhances the oocyte sensitivity to MIH, i.e. oocyte maturation competence, 
by increasing MIH receptor activity (29) and gap junction contacts (30) whereas in 
the second stage, it elevates 20p-HSD expression and activity and thus triggers the 
production ofDHP (31). 
1.1.3 Oocyte Control of Folliculogenesis 
Steroids are not the only paracrine factors working within the antral 
follicle. Lines of evidence have demonstrated the existence of various local ligands, 
particularly growth factors, in distinct groups of ovarian cells. The local growth 
factors either support or restrain follicular development by amplifying or attenuating 
the effects of endocrine hormones, respectively (1). The interplays of these growth 
factors and their interactions with endocrine hormones form a sophisticated 
intrafollicular signaling network within the follicles. 
The importance of the somatic follicular cells in nurturing and supporting 
the oocyte has been appreciated for decades. For long time, the oocyte was 
considered as a passive regulatory target during folliculogenesis. But recent studies 
have revealed that this is far from the case. The oocyte appears to act actively in 
folliculogenesis not only by regulating the growth and differentiation of adjacent 
follicular cells, but also modulating their responsiveness to endocrine signals 
(Reviewed in REF. 32, 33, 34). The search for oocyte-derived regulatory factors 
was first inspired by the pioneering experiment which showed that the removal of 
the cumulus-oocyte complex resulted in precocious luteinization of rabbit follicles 
(35). Clearly the interpretation was that an anti-luteinization factor might be 
secreted by the oocyte. To date, a number of oocyte-derived factors have been 
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identified, with the best-characterized one being the oocyte-specific growth 
differentiation factor 9 (GDF-9). In GDF-9 knockout mice, folliculogenesis is 
J 
arrested at preantral stage (36) followed by the degeneration of the oocyte and 
spontaneous luteinization (37). Detailed analysis showed that GDF-9 modulates the 
follicular cells by stimulating granulosa cell proliferation (38) and suppressing their 
apoptosis (39) and the expression of LH receptor (LHCGR) to repress luteinization 
(40). Belonging to the same transforming growth factor |3 family as GDF-9, bone 
morphogenetic protein 15 (BMP-15) is another intensely studied oocyte-derived 
factor. Though BMP-15 null sheep displayed phenotypes similar to that observed in 
GDF-9 null mice (41), it appears that BMP-15 null mice showed no anomalistic 
follicular development but just reduced fertility (42). However, double mutant mice 
for BMP-15 and GDF-9 got more profound fertility defects, suggesting a synergism 
between BMP-15 and GDF-9 in follicle development in mice (42). Besides GDF-9 
and BMP-15, there are still some other oocyte-derived factors which orchestrate 
folliculogenesis from the very beginning primordial follicle formation to the 
eventual ovulation (33, 34). 
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1.2 Epidermal Growth Factor Family 
s 
1.2.1 Epidermal Growth Factor Ligand Family 
1.2.1.1 Discovery 
The whole story on epidermal growth factor (EGF) family of ligands 
started in 1962, when Stanley Cohen discovered that a peptide isolated from mouse 
submaxillary gland could cause "unexpected side effects" of stimulating precocious 
eyelid openings and tooth eruption (43). In the consecutive years, Cohen further 
demonstrated that the peptide stimulated epidermal keratinization in whole mouse 
(44) and later in epidermal cell culture (45). These findings gave the protein its 
name, epidermal growth factor. The story then went along in the way that Cohen 
probably had never imagined. This "made-by-accident" discovery, as described by 
Cohen himself (46), won him a Nobel Prize in 1986. The story became even more 
engrossing when scientists uncovered that EGF after all was just a prelude and the 
sequel was an extensive growth factor family comprising hitherto eleven ligands and 
four receptor proteins (47). 
The second ligand transforming growth factor a (TGFa), produced by 
sarcoma virus and conferred transformed phenotype on fibroblasts, was discovered 
by Cohen's team in 1976 (48, 49). It was not until 1988 the third ligand 
amphiregulin (AREG), named according to its amphibious effect on cancer and 
normal cells, was discovered and characterized (50, 51). Then, nearly every one or 
two years, a new ligand of the family was discovered; successively heparin-binding 
EGF-like growth factor (HB-EGF) (52), neuregulin (53) and its four isoforms (54), 
betacellulin (BTC) (55，56), epiregulin (EREG) (57, 58) and lastly epigen (59). 
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1.2.1.2 Structure 
The defining structural characteristic of the EGF ligand proteins is the EGF 
domain, which consists of six consensus cysteine in 36-40 amino acid residues in 
the sequence CX7CX4-5CX10-13CX1CX8C (60). The cysteine residues form three 
intramolecular disulfide bonds (C1-C3, C2-C4, C5-C6) which confer the domain its 
three-looped tertiary structure and thus critical in binding ErbB receptor proteins 
(the group of receptors that bind EGF ligand family, to be discussed later) (61). 
Besides the cysteine residues, the Gly 18 and Arg 41 residue are also conserved 
across the family (62). Despite these similarities, the members of the EGF ligand 
family indeed have relatively low homology with each other at amino acid level. 
The variation in amino acid residues at binding site of the ligands offers them 
distinct ability to bind different ErbB receptors and with different affinity. 
1.2.1.3 Shedding 
All the ligands in the EGF family are synthesized as type I transmembrane 
protein precursors. Upon proteolytic cleavage adjacent to the plasma membrane, the 
mature soluble growth factor is released to bind the receptors. This process, named 
as shedding, acts as post-translational regulator of the ligands and controls their 
bioavailability (63, 64). Several types of metalloprotease families (the zinc-
containing proteases) are implicated in shedding of EGF family ligands, including a 
disintegrin and metalloprotease (ADAM) (65, 66) and matrix metalloprotease 
(MMP) families (67). Different ligands are processed by different 
metalloprotease(s). For example, ADAM 17 is involved in shedding of TGFcx, HB-
EGF, EREG, AREG and epigen while BTC and EGF are susceptible only to ADAM 
10 (65,66). 
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There is little homology of amino acid sequence between the cleavage sites 
of various ligands (60), presumably meaning that no specific sequence is necessary 
for recognition of shedding. Besides, it has been found that shedding of EGF family 
is constitutive (68) but can be up-regulated by numerous stimulants, e.g., protein 
kinase C (PKC) (69). Several experiments using ADAM knockout mice as models 
demonstrated that they had anomalous phenotypes mimicking those lacking EGF 
family ligands or EGF receptor (70, 71), suggesting that the proteolytic release of 
the ligands is essential in paracrine and autocrine EGF family signaling. 
Nonetheless, recent studies, particularly that on HB-EGF, demonstrated that the 
membrane-anchored ligands might bind EGF receptor (EGFR) in an juxtacrine 
manner and exert effects different from those of shedded ligands (72). 
1.2.1.4 Functions 
Although the EGF family was initially known by its epithelial mitogenic 
capacity, it is indeed involved in far more physiological and pathological processes 
in diverse tissues. It not only regulates growth, maturation, function and 
maintenance of diverse tissues but also emerges to malignancy when aberration 
occurs (73). 
The biggest mystery that puzzles the scientists is the existence of multiple 
ligands in the EGF family. It tempts scientists to investigate whether the functions 
of the multiple ligands are redundant or specific. Numerous knockout experiments 
have been done to answer this question. It is well established that EGFR null mice 
show overt abnormal phenotypes such as impaired epithelial development, growth 
retardation, shortened lifespan (74) and pituitary hypoplasia (75). But in an 
experiment that knocked out the EGF, TGFa and AREG genes, the triple null mice 
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remained healthy and fertile (76). This contrary implies that some functions of the 
EGF ligands are, to a certain extent, compensatory and redundant to assure that 
/ 
lacking one or several members cannot pose a severe and fatal aberration to the 
organism. On the other hand, only the AREG null mice got impaired mammary 
gland development and only the TGFoc null mice exhibited eye and hair follicle 
defect (76). Also the ligands display spatial and temporal deviation in expression; 
they exist predominantly in different tissues (60) or in the same tissue but at 
different time (77). Together, it indicates that some functions of the EGF ligands 
are unique and specific. In addition, some scientists proposed that apart from 
redundant and specific activities, the functions of different ligands can be somewhat 
cooperative or cumulative (76), further increasing the complexity of the EGF 
system. 
1.2.2 Epidermal Growth Factor Receptor (EGFR) Family 
1.2.2.1 Structure 
Two decades after the discovery of the ligands, Cohen and his team 
eventually isolated and characterized the receptor of EGF from a human tumor cell 
line (78) and mouse liver (79) in 1982. The receptors isolated in both species were 
170 kDa transmembrane glycoprotein which, upon EGF-stimulation, demonstrated 
kinase activity specific for tyrosine residues and capacity of autophosphorylation 
(78-80). Since then, three homologues of EGFR have been discovered owing to 
their close DNA sequence similarity to that of EGFR (81-83). Henceforth, EGFR 
(also known as ErbBl, HER), ErbB2 (HER2, Neu), ErbB3 (HER3) and ErbB4 
(HER4) were grouped into the same ErbB family, denominated by their homology 
to the avian erythroblastosis tumour viral gene product, v-erbB (84). 
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The ErbB family belongs to subclass I of the receptor tyrosine kinase 
(RTK) superfamily (85). The common characteristics they all share include the 
amino-terminal extracellular ligand-binding domain (86, 87), the a-helical single 
membrane-spanning domain (88), the juxtamembrane domain (89), the cytoplasmic 
tyrosine kinase domain (90) and the carboxyl-terminal tail possessing 
autophosphorylation motifs. Crystallographic studies of the extracellular domain 
revealed that it consists of four subdomains. The (3-helical leucine-rich subdomains 
I and III serve for ligand binding, whereas the constitutional interaction between 
cysteine-rich subdomains II and IV hinders receptors dimerization (86, 87, 91). In 
spite of these structural analogies, the greatest and most striking feature that 
distinguishes the ErbBs from each other is that ErbB2 and ErbB3 are not 
autonomous. They can barely trigger any downstream signaling events when 
working alone but must form heterodimer with other member of the ErbB family. 
ErbB2 lacks direct ligand-binding ability (92, 93) and, contrariwise, ErbB3 is 
impaired in intrinsic tyrosine kinase (94). 
1.2.2.2 Ligand Binding and Dimerization 
Based on the affinity toward different ErbB members, the ErbB ligands can 
be divided into three groups. EGF, TGFa and AREG are grouped since they all 
bind solely to ErbBl (EGFR). BTC, HB-EGF and EREG belong to the group that 
binds to both ErbBl and ErbB4. The last group comprised the neuregulins which 
bind to ErbB3 or ErbB4 (85). 
It is well established that dimerization of ErbB is a prerequisite for 
activation of the receptors (95). Although both monomeric and dimeric forms of 
ErbB members are present in cells without ligand stimulation (96, 97), only dimer 
-11-
formation initiated by ligand binding can activate the cytoplasmic kinase activity 
(97, 98). Innumerable studies have been done to understand how the binding of 
ligands impels the dimerization of the receptors (Reviewed in REF. 99, 100). The 
ErbB dimerization is regarded as a novel mechanism since it is exclusively receptor 
mediated (87). Compendiously summarized, the binding of the ligands to 
subdomains I and III brings a conformational change to the extracellular domains 
and thus break the inhibitory interaction between subdomains II and IV. 
Subsequently, the subdomain II is exposed to dimerize with other ErbB (86, 101). It 
is noteworthy that, albeit with no ligand-binding ability, the ErbB2 was found to be 
the preferable heterodimer partner of other ErbB (102). 
1.2.2.3 Signaling and Internalization 
Like other RTK, the autophosphorylation site of the cytoplasmic domain of 
ErbB serves as binding site for SH2 (Src homology 2) or PTB (phosphotyrosine 
binding) domains of various signaling proteins (103). Thus upon ligand binding and 
receptor dimerization, multiple pathways are simultaneously activated (Reviewed in 
REF. 85, 104-106). The nature and potency of activated pathways depend not only 
on the identity of the ligand but also on that of the receptor (107). For instance, the 
Ras/MAPK (mitogen-activated protein kinase) pathway activated by She and/or 
Grb2 is a universal pathway of all receptors (108, 109) while the 
phosphatidylinosithol-3-kinase (PI3K) activated Akt pathway is activated directly 
by ErbB3 and ErbB4 (110) but only indirectly by ErbBl (111). Besides, ErbBs are 
also involved, to a lesser extent, in activating the PLCy (Phospholipid C-Y)-mediated 
PKC cascade (112), the STAT (signal transducer and activator of transcription) 
pathway (113) and so on. Different signaling pathways finally lead to distinct 
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transcriptional programmes and supervene different cell responses including cell 
proliferation, differentiation, migration, adhesion and apoptosis. 
Dimerization of receptors induces the migration of the dimers to clathrin-
coated regions of the plasma membrane followed by invaginating to form vesicles 
(114). ErbBl is the only member which can undergo endocytosis while the other 
ErbB proteins were found to be endocytosis impaired and hence are mostly recycled 
back (115). The final destiny of ErbBl depends on its dissociation rate with the 
ligands. Dissociating with the ligand (e.g., TGFa) results in recycling whereas 
continuous binding and activation (e.g., EGF) directs the receptor to lysosomal 
degradation (116). As internalization is considered as the major way to attenuate the 
ErbB signaling and determine the continuance of EGFR signaling (114), the choice 
of ligands not only determines the nature of the signal but also it continuance, 
further unraveling the existence of multiple ligands. 
1.2.3 EGF Family in Reproduction 
1.2.3.1 Reproductive Function of EGF Family 
The study of EGF in reproduction can be traced back to 1977, even before 
the EGFR was identified. It was found that EGF could stimulate DNA synthesis and 
proliferation of bovine, porcine and human granulosa cells in vitro (117, 118). But 
the breakthrough on EGF involvement in reproduction came from the studies on its 
actions other than its mitogenic activity. In the early 1980s，EGF was implicated in 
suppression of FSH-induced LHCGR induction (119) and stimulation of rat follicle-
enclosed oocyte maturation (120). TGFa was also found to be produced locally by 
ovarian cells (121). Since then, multitudinous studies have been done to scrutinize 
the role of EGF family in reproduction. It has been discovered that EGF family 
-13-
regulates female reproduction by affecting every layer of the hypothalamic-
pituitary-ovarian axis as well as implantation afterward (122, 123). The ovarian 
J 
function of EGF family would be the major emphasis of the discussion here due to 
its relevance to the current study. 
Lines of evidence showed that, with the exception of epigen and 
neuregulins, the EGF family participates in modulating several key ovarian events. 
EGF, TGFa, AREG, EREG and BTC were recognized to stimulate cumulus 
expansion and final oocyte maturation. The capability of EGF ligands in stimulating 
oocyte maturation is highly conserved among different species. In mammals, EGF 
ligands have been implicated in stimulating oocyte maturation in murine (120, 124), 
bovine (125), feline (126), porcine (127), ovine (128) and human ovary (129). 
Likewise in fish, EGF and TGFa stimulated reinitiation of oocyte meiosis (130). 
Together with the high degree of redundancy of EGF ligands in stimulating oocyte 
maturation, the family appears to be essential in modulating folliculogenesis. 
Apart from folliculogenesis, EGF family is also involved in 
steroidogenesis, another key ovarian event. Specifically, EGF increased 
progesterone, testosterone and estradiol level in oocyte-granulosa cell cultures and 
oocyte-cumulus cell complex (131). Furthermore, a recent in vivo study employed 
mutant mice to demonstrate that ovulation would also be impaired if component(s) 
of the EGF network were missed (132). 
Over and above the redundant functions of the EGF family, some ligands 
exhibit features that have yet been uncovered for the other family members. For 
instance, overexpressing BTC in the mouse ovary reduced the litter size by 
impairing fertilization that is in turn caused by hyperactivation of MAPK3/MAPK1 
(133). However, for HB-EGF, its role in mammalian ovarian function seems to be 
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equivocal because an in vitro study showed that the shedded and membrane-
anchored forms of HB-EGF displayed opposing roles by inhibiting or enhancing 
J 
apoptosis of human luteinized granulosa cells respectively (72). Nevertheless, in 
chicken, HB-EGF was lately proposed as an oocyte-derived factor to control 
granulosa cell proliferation (134). 
1.2.3.2 EGF Network as Downstream Mediator of Gonadotropins 
In spite of the extensive reproductive functions of the EGF family, their 
significance had never been appreciated as much at the time when Park et al 
proposed that EGF-like ligands may act as the downstream mediators of LH (124). 
Several lines of convincing evidence were presented to support the hypothesis. 
First, AREG, EREG and to a lesser extent BTC stimulated mouse oocyte maturation 
and cumulus expansion in vitro as LH did, but required a shorter time than LH to 
achieve their function. Second, in vivo injection of hCG stimulated expression of 
the three ligands in granulosa cells of the preovulatory follicles and caused delayed 
phosphorylation of EGFR. Last but not the least, tyrphostin AG 1478, inhibitor of 
EGFR tyrosine kinase, blocked the LH-induced oocyte maturation and cumulus 
expansion. All together, a model has been proposed that LH stimulation results in 
accumulation of EGF ligands which then bind to their receptor to mediate LH action 
in the ovary (135). 
After this report, dozens of studies were done to further elucidate the role 
of the EGF family and its relationship with gonadotropins. Another experiment 
carried out in mouse revealed that in addition to oocyte maturation, EGFR signaling 
is also critical in LH-induced steroidogenesis (131). It was then proved that the 
model also applied to the rat, with additional in vivo data depicting that tyrphostin 
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AG 1478 injection into the bursa reduced ovulation rate to nearly half (136). The 
same study also demonstrated that shedding of EGF ligands was essential for LH 
/ 
action since Galardin, a metalloprotease inhibitor, abrogated LH-induced oocyte 
maturation. 
The model was recently consolidated by genetic evidence thanks to the 
generation of knockout mice that were null for amphiregulin and carried a 
hypomorphic EGFR allele (132). These knockout mice are not only defective in 
LH-induced oocyte meiotic resumption, but also incapable of inducing genes 
involved in follicle rupture and cumulus expansion. As a matter of course, ovulation 
of these mice was impaired. 
While most of the studies focused on LH being upstream of EGF family, 
some recent studies appeared to put FSH together in the model. It was proved in pig 
(127) and mouse (137) that FSH up-regulated the expression of AREG in vitro and 
tyrphostin AG 1478 suppressed the FSH-induced oocyte meiotic resumption. 
Moreover, PKC seems to act downstream of FSH and upstream of EGFR. It is also 
noteworthy that, among the EGF family, AREG and EREG seem to be the key 
members subjected to regulation by gonadotropin since considerable experiments 
had presented result that EGF and HB-EGF were insensitive to endogenous nor 
exogenous gonadotropins (127, 135) while BTC was irresponsive in some cases 
(138) or responded to a lesser extent than AREG or EREG in the others (124). 
In all, this model reasonably explains the formerly enigmatic question how 
gonadotropins work without their receptor on the oocyte. The whole picture, 
however, appears to be much more sophisticated due to the ongoing studies which 
are adding more local factors or signaling molecules into the model. Prostaglandin, 
for example, was proposed as a bridge that links gonadotropins receptors to the 
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growth factors (139, 140). But no matter how complicated the model goes, it is 
doubtless that the role played by the EGF family is indispensable in the whole 
/ 
reproductive process. Besides, the EGF family also commendably exemplifies the 
important role of growth factor-mediated paracrine signaling in fine-tuning the 
endocrine signals. 
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1.3 Objectives of the Present Study 
The reproductive role of the EGF family is well characterized in mammals 
and lately they are regarded as the downstream mediator of gonadotropins. 
Nevertheless, previous study of our laboratory on zebrafish has located the EGF 
expression in the oocyte whereas EGFR in the follicle cells (141). The lack of 
receptor in oocyte seems to blur the possibility of the EGF family to act as mediator 
of gonadotropins to signal the oocyte. Therefore it is of great interest to study the 
EGF family in fish ovary in order to examine the reproductive discrepancy, if any, 
between fish and mammal. Hopefully this can shed light on the change of 
reproductive strategy throughout evolution. In addition, in lower vertebrates like 
teleosts, limited studies have been carried out on the role of EGF family in 
reproduction. Though it has been reported that EGF and TGFa also stimulate 
folliculogenesis and steroidogenesis in fish (130, 142-145), up to now there is no 
investigation on the reproductive role of other EGF ligands in fish. The present 
study is, therefore, undertaken to investigate the EGF family in teleost ovary using 
zebrafish as a model. 
Zebrafish, Danio rerio, has caught increasing attention from the scientists 
since late 1970s. Benefited from its small body size, short life cycle and transparent 
embryo, it has risen as a top model organism that is poised to contribute to our basic 
understanding of vertebrate development (146). The usage of zebrafish therewith 
went beyond developmental biology to physiology (147). Its relatively large and 
asynchronous ovary supplies different stages of follicles year-round for reproductive 
study. In recent years, our laboratory has been exploring the framework of 
intrafollicular regulatory network in the zebrafish ovary (148), which makes it an 
excellent model for the present study. Therefore using zebrafish as model, the 
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present study aims at study ® the spatiotemporal localization of the EGF family in 
o v a r y , � the regulation of the EGF family and � the interaction between the EGF 
and activin family. This information definitely offers basic knowledge on 
reproductive role of EGF family in non-mammalian vertebrates. 
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Chapter 2 
Spatiotemporal Expression of the EGF Family in Zebrafish Ovary 
2.1 Introduction 
Though the effect of EGF in stimulating granulosa cell proliferation was 
identified in 1977 (117), it was not until ten years later scientists discovered that 
ovarian theca cells produced an epidermal growth factor-like substance locally 
(121), which was later identified to be TGFa. Since then, there have been dozens of 
reports on the spatiotemporal localization of the EGF ligands and their receptors in 
the ovary of various species ranging from Drosophila to mammals. In DrosopMa, a 
TGFa-like molecule Gurken has been localized in the oocyte while its receptor 
EGFR has been demonstrated in the surrounding follicle cells (149, 150). EGFR, 
EGF and TGFa were also detected in chicken granulosa, theca interna and theca 
externa layers by immunohistochemistry and their concentration decreased with 
follicle maturation (151). In mammals, however, the results from different studies 
and different species cannot reach a consistent conclusion, making the picture still 
confusing. Despite the studies in other vertebrates, the localization of EGF family in 
teleost ovary is scarce. Pati et al. reported the existence of high-affinity binding 
sites for EGF in goldfish ovarian membrane preparations (130), but still no 
information regarding the spatial distribution of the EGF family within the follicle 
was provided. Our laboratory recently cloned the full-length cDNAs of egf (EGF) 
and egfr (EGFR) from zebrafish ovary and their spatiotemporal distribution pattern 
have been investigated by semi-quantitative RT-PCR (141). The predominant 
expression of egf'm oocyte and exclusive expression of egfr in follicular layer led us 
to hypothesize that the oocyte-derived EGF may signal the follicle cells in a 
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paracrine/juxtacrine manner. 
Another group of important intraovarian regulators, activins, belong to the 
J 
transforming growth factor-p superfamily, which act primarily as local growth and 
differentiation factors in a wide variety of tissues. Activins are dimeric proteins and 
the subunit Pa and Pb dimerize to give three possible types of activin species, i.e. 
activin A, B and AB (152). Activin exerts its actions by binding to its specific type I 
and type II receptors. The activities of activins are regulated extracellularly by 
follistatin, a protein that binds activins nearly irreversibly to neutralize their effects. 
Activins have been implicated in modulating various ovarian functions including 
granulosa cell proliferation and differentiation (153), steroidogenesis (154), oocyte 
maturation (155) and even FSH receptor numbers (156) in mammals. Similar to the 
EGF family, the study on the role of activins in teleost ovary is relatively limited. 
Our laboratory has demonstrated that activin stimulates zebrafish oocyte maturation 
in vitro (157) and enhances maturational competence of oocyte (158). Since EGF 
and TGFa also have the capacity of promoting oocyte maturation in zebrafish and 
their effects could be blocked by activin binding protein follistatin (145), this points 
to an potential interaction between the EGF family and the activins. 
The present study aimed at extending the spatiotemporal distribution 
experiment to other EGF ligands and receptors using real-time PGR to complete the 
entire picture of the EGF family in zebrafish ovary. Besides, the spatial patterns of 
the activin family within the follicle were also investigated using an improved 
separation technique to further elucidate its relationship with the EGF family. 
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2.2 Materials and Methods 
2.2.1 Chemicals 
All chemicals were obtained from Sigma-Aldrich (St. Louis, MO) unless 
otherwise specified. Modified Cortland's medium without calcium and magnesium 
ions contains 0.125 M NaCl, 0.012 M NaHCCb, 0.003 M Na2HP04, 0.005 M KCl, 1 
mM NaiEDTA, 1 g BSA, 1 g HEPES, 0.03 g penicillin, 0.05 g streptomycin in 1 L 
of ultra pure water. 
2.2.2 Animals 
Zebrafish were purchased from local fish stores and maintained in flow-
/ • 
through aquaria at 28 土 on a photoperiod of 14L:10D. The fish were fed with 
commercial tropical fish food twice a day and acclimated for at least two weeks 
before use. All experiments were performed under license from the government of 
the Hong Kong Special Administrative Region and endorsed by the Animal 
Experimentation Ethics Committee of The Chinese University of Hong Kong. 
2.2.3 Isolation of Different Tissues and Ovarian Follicles 
The zebrafish were anesthetized with ethyl 3-aminobenzoate 
methanesulfonate (MS-222) or ice shock and decapitated before dissection. Eight 
different tissues were isolated from zebrafish, including gill, brain, muscle, liver, 
kidney, testis, ovary and pituitary. Liver and kidney were specifically isolated from 
male zebrafish to prevent contamination from ovarian follicles. For isolation of 
ovarian follicles, the two ovaries were carefully removed and placed in a dish 
containing Cortland's medium. The follicles of different stages were manually 
isolated under microscope. 
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2.2.4 Separation of Oocyte and Follicle layer 
The full-grown follicles were pretreated in Cortland's medium without 
calcium and magnesium ions but with NaiEDTA for about an hour to reduce the 
cohesion between the oocyte and the follicle layer. The follicle layer was peeled off 
from the intact oocyte with fine forceps. The isolated follicle layers and the 
denuded oocytes from five follicles were pooled for RNA extraction. All the total 
RNA from five follicular layers or oocytes was reverse transcribed followed by PCR 
amplification, therefore the comparison of the expression levels in the two 
compartments was follicle-based rather than based on the amount of RNA. 
2.2.5 Embryo Collection 
Female and males zebrafish were maintained in separate aquaria before 
breeding. Zebrafish of sex ratio 1:1 were placed in the same aquarium at 28 
before the day of embryo collection. Embryos were collected from the aquarium at 
9:00 am and incubated in Embryo Medium (159). After different incubation times, 
five embryos of the same developmental stages were identified according to their 
morphology and pooled for RNA extraction followed by real-time RT-PCR analysis. 
2.2.6 Tyrphostin AG 1478 Treatment of Embryos 
Tyrphostin AG 1478 , 4-(3'-Chloroanilino)-6,7-dimethoxyquinazoline, was 
added to 100 ml Embryo Medium with embryo inside to make up a concentration of 
1 [xM or 5 \xM and the medium was changed with the drug everyday. The embryos 
were examined under microscope Leica MZ 12 (Leica Microsystems GmbH, 
Wetzlar, Germany) and were photographed with Nikon DS-Fi 1 (Nikon, Tokyo, 
Japan) installed with the microscope. 
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2.2.7 Total RNA Isolation and Reverse Transcription 
Total RNA samples were isolated from the tissues, ovarian follicles and 
embryos using Tri-Reagent (Molecular Research Center, Cincinnati, OH) according 
to the manufacturer's protocol and our previous report (160). Reverse transcription 
was performed at 37 °C for 2 h in a total volume of 10 \x\ reaction solution 
consisting of 0.5 jig oligo(dT), IX M-MLV RT buffer, 0.5 mM each dNTP, 0.1 mM 
DTT, and 100 U M-MLV reverse transcriptase (Invitrogen, Carlsbad, California). 
2.2.8 Semi-quantitative and Real-time Polymerase Chain Reaction (PGR) 
The primers for PGR were designed according to the sequences available in 
the GenBank and were synthesized by Integrated DNA Technologies, Inc. 
(Coralville, Iowa) (Table 2.1). For non-quantitative measurement of the mRNA 
expression, conventional PCR and agarose gel electrophoresis were performed. The 
cycle numbers were optimized by the same method mentioned in our previous report 
(141) but two cycles higher than the optimized one were used to ensure 
amplification of weakly expressed genes. The PCR was performed in a total volume 
of 15 jil containing 5 of 1:15 diluted RT products, IX PCR buffer, 0.1 mM each 
dNTP, 1.25 mM MgCh, 0.1 [xM each primer, 0.375 U Taq Polymerase at a profile 
of 30 sec at 94 30 sec at 56 for btc, acvrlb, acvr2a and acvr2b, 58 for 
hbegf, inhba’ inhbb and fst, 60 for efla, erbb2, erbbSa, erbbSb and erbb4, 62 °C 
for egf, tgfa, egfr, Ihcgr, fshr, and gdf9, and 40 sec at 72 The PCR products 
were then visualized in 1.6 % agarose gel containing ethidium bromide. 
Real-time PCR was performed for the quantitative analysis. The standards 
for real-time PCR were prepared by PCR amplification of cDNA fragment with 
specific primers. The amplicons were resolved by agarose gel electrophoresis, 
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purified and quantified by comparing to the Mass Ruler DNA marker (MBI 
Ferments, Hanover, MD). The amplicons were used to make the standard curve of 
J 
real-time PCR. The real-time PCR were performed in a total volume of 30 [il 
containing 10 \x\ of 1:20 diluted RT products, IX PCR buffer, 0.2 mM each dNTP, 
2.5 mM MgCli, 0.75 U Taq polymerase, 0.5X EvaGreen (Biotium, Hayward, CA) 
and 20 nM fluorescein (Bio-Rad, Hercules, CA) on the iCycler iQ Real-time PCR 
Detection System (Bio-Rad). The reaction profile was the same as that of semi-
quantitative PCR besides a signal detection period of 7 sec at 80 °C. A melt-curve 
consisting of 180 cycles of 7 sec in which temperature increased at a rate of 0.2°C 
per cycle was constructed at the end of the reaction to analyze the specificity of the 
amplification. 
2.2.9 Data Analysis 
All the experiments were performed at least twice to confirm the results. 
Then the data from one individual experiment were chosen to represent the result 
and the replicate number in each experiment was indicated by “n” in the legend of 
figures. The mRNA level of each target gene was first normalized to the 
housekeeping gene efla (elongation factor 1 -alpha) and then expressed as 
percentage or fold change of the control group. All values were expressed as mean 
土 SEM For some of the graphs, the result were plotted in two graphs such that one 
graph was normalized to the housekeeping gene efla whereas the other one was not. 
The graph without normalization served to prove that the change of the expression 
was due to the change of target gene but not that of the housekeeping gene. 
Statistical analysis was carried out by the GraphPad Prism 5 for Mac OS X 
(GraphPad Software, San Diego, CA). One-way ANOVA followed by Newman-
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2.3 Results 
2.3.1 Validation of Semi-quantitative PGR Quantification 
Four members of the EGF family ligands, namely egf, tgfa, btc and hbegf, 
and all four of the ErbB receptors were previously cloned and their nucleotide 
sequences were found in the GenBank (reference numbers were shown on Table 
2.1). The primers are designed according to the available sequences and the half-
maximum cycle was determined and used as the optimal cycle number for each 
gene. In case the curves did not plateau even though 40 cycles were used, the 
middle points at the linear region were chosen as the optimized cycle numbers and 
they were 28 for btc (Fig. 2.1 A) and 30 for both tgfa and hbegf (Fig 2.1 B and C). 
2.3.2 Tissue Distribution of the EGF Family 
To investigate the involvement of different EGF family ligands in the 
function of different systems, their expression distribution in different tissues were 
examined by RT-PCR (Fig. 2.2). gdf9 (growth differentiation factor 9) was used as 
the control for the gonad and its absence in other tissues indicated that there is no 
contamination of the ovarian follicles to other tissues. Among the four ligands, egf 
was the only one which showed predominant expression in the gonads. For the 
other three ligands, they were expressed nearly universally in almost all organs. 
2.3.3 Spatial Expression of the EGF and the Activin Families within the Follicles 
The distribution of the EGF family in the two compartments of full-grown 
follicles was examined by manually separating the follicular layer from the intact 
oocyte (Fig. 2.3 A). Ihcgr (luteinizing hormone/choriogonadotropin receptor) and 
gdf9 were previously demonstrated by our lab to be exclusively expressed in the 
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follicular layer and oocyte, respectively (161), making them excellent markers for 
these two compartments. Thus they were included in the experiment to prove the 
/ 
clean separation of the two compartments. Another gonadotropin receptor, fshr 
(follicle stimulating hormone receptor), was also expressed in the follicular layer 
only (Fig. 2.4). 
All the ligands examined were found to be expressed only in the oocyte 
with the exception of btc, which was also expressed in the follicular layer albeit at 
much lower level compared to its expression level in the oocyte. Interestingly, in 
contrast to the ligands, the common receptor for these ligands, egfr, was expressed 
exclusively in the follicular layer (Fig. 2.4). 
The spatial distribution of the subunits of activin, its receptors as well as its 
binding protein follistatin was also examined in this experiment. In contrast to EGF 
family of ligands and their receptor, the subunits of activin, inhba (activin Pa) and 
inhbb (activin (3B), were found to express exclusively in the follicular layer whereas 
activin receptors acvrlh (type IB), acvr2a (type IIA) and acvr2b (type IIB) were 
localized predominantly in the oocyte. Interestingly, the binding protein fst 
(follistatin), instead of existing in the same compartment as activin, was also found 
only in the oocyte (Fig. 2.4). 
And for the other EGF receptor family members, erbb2 was expressed in 
the follicular layer together with egfr (erbbl) while erbbSa, erbbSb and erbb4 were 
localized in the oocyte (Fig. 2.5). In contrast to egfr, significantly high cycle 
numbers (> 35) were needed to amplify erbb2, erbbS and erbb4 to a barely 
detectable level (Table 2.1), which may possibly imply very low expression levels 
of these receptor types in the zebrafish ovary. Therefore they were not included in 
later quantitative experiments. 
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2.3.4 Temporal Expression of the EGF Family in Folliculogenesis 
In order to assess the possible role of the EGF family in folliculogenesis, 
J 
the follicles were separated into five stages according to their degree of development 
indicated by the size and the amount of vitellogenin deposited. The stages included 
primary growth (PG), previtellogenic (PV), early vitellogenic (EV), midvitellogenic 
(MV) and full-grown but immature follicles (FG) (Fig. 2.3 B). Consistent with our 
previous results, Ihcgr increased progressively during folliculogenesis but with a 
surge from the MV to the FG stage (Fig. 2.6 A) while fshr increased until it reached 
its maximum level at the MV stage and dropped significantly at the FG stage (Fig. 
2.6 B). For egfr, its expression increased from PG to PV stage, remained constant at 
EV and MV stage but with a further increase from MV to FG stage (Fig. 2.6 C). 
Among all the EGF family ligands examined, egf and tgfa are the ones that showed 
a larger fluctuation (Fig. 2.7). They both increased from PG to PV stage, for 4- to 6-
folds, respectively, and remained quite constant till the decrease at FG stage (Fig. 
2.8 A and B). The expression of hbegf was more stable throughout folliculogenesis 
with a slight increase from PG to PV stage followed by a gradual decline in later 
stages (Fig. 2.8 C). The expression of btc showed a unique slight decreasing trend 
(Fig. 2.8 D). In order to access the relative abundance of each target gene, another 
set of graphs representing the ratio of copy number of target gene over that of 
housekeeping gene efla without normalization to the control group PG was plotted 
(Fig. 2.9). As seen in Y-axis of the graphs, btc was the one with strongest 
expression among the ligands while egf was the most weakly expressed one. 
2.3.5 Temporal Expression of the EGF Family in Embryogenesis 
To study the expression profiles of the EGF family ligands after 
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fertilization, the embryos were divided into 7 stages from the 4-cell stage to the 
hatched fish (Fig. 2.3 C). The housekeeping gene efla increased its expression 
significantly from shield stage (Fig. 2.10 A). The expression of egfr dropped to 
nearly undetectable level immediately after fertilization. Its expression remained 
low until the bud stage and increased again significantly at later stages (Fig. 2.10 B). 
The expression levels of the ligands all displayed a declining trend after fertilization 
and almost completely shut down at the shield stage. The expression of tgfa and btc 
remained extremely low afterwards (Fig. 2.11 B and D); however, the expression of 
egf and /z^eg/"increased significantly again from the 8-somite stage (Fig. 2.11 A and 
C). 
2.3.6 Effect of Blocking EGFR on Embryonic Development 
The EGFR inhibitor tyrphostin AG 1478, 4-(3'-Chloroanilino)-6,7-
dimethoxyquinazoline, was added to the medium to study the functionality of the 
EGF family during embryo development. This drug blocks the tyrosine kinase 
activity of EGFR by competing with adenosine triphosphate (ATP) in the kinase 
reaction. It was found that when 5 \xM of tyrphostin AG 1478 was added to the 
incubation medium, the embryos started to show delayed development 7.5 h after 
fertilization, i.e. at the shield stage. And at later stage, abnormal morphology was 
observed and the hatching rate decreased significantly (Fig. 2.12). 
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2.4 Discussion 
In mammals, egf, tgfa, btc and hbegf gene expression has been 
J 
demonstrated in multiple tissues including the gonads (162-164). In this study, 
whereas the others were expressed universally in almost all organs, egf is the only 
ligand that showed predominant expression in the gonads. This underscores the 
importance of EGF in teleost reproduction compared with other ligands. The 
expression of tgfa, btc and hbegf in organs other than the gonads explains our 
previous result that egfr was expressed ubiquitously in all tissues (141). 
Though the spatial distribution of EGF ligands and EGFR within the 
follicles has been studied in other species, a consistent result cannot be reached by 
different reports. EGFR, EGF and TGFa were usually immunohistochemically 
localized to both follicular layer and oocyte in mammals with their expression 
occurring in a highly regulated manner (165-169). Nonetheless, EGFR was 
localized only on granulosa and theca cells in some cases (170). In chicken, some 
studies reported exclusive localization of EGFR and TGFa in the theca and 
granulosa cells (151) while EGF but not TGFa was localized in the germinal disc 
and was proposed as a paracrine factor to regulate granulosa cell proliferation and 
inhibit apoptosis (171-173). For HB-EGF, the picture is confusing since it was 
expressed in the granulosa cells of developing follicles in the rat (174) but its 
expression could not even be detected in human follicles nor oocyte but only in 
granulosa luteal cell of corpus luteum (175). Interestingly, hbegf was recently 
shown to express in growing chicken oocyte but with minor expression in granulosa 
cell (134). Therefore, the exclusive localization of egf, tgfa and hbegf in the oocyte 
and egfr in the follicular layer in this study appears to be the first report in 
vertebrates and hence reveals the presumably differential roles of the EGF family 
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ligands in teleosts and in other vertebrates. The localization of other EGF ligands in 
oocyte further validates our previous hypothesis that the EGF ligands may serve as 
/ 
oocyte-derived factors to regulate the function of the follicular layer in a paracrine 
manner (141). btc is the only ligand whose expression could also be found in the 
follicular layer. The appearance of btc and the gonadotropins receptor in the same 
compartment is not surprising because it has recently been proposed as one of the 
downstream mediators of LH together with amphiregulin and epiregulin in 
mammals (124, 135, 136). Thus whether BTC is subjected to gonadotropin 
regulation deserves further investigation. 
Besides the ligands, the spatial distribution of the ErbB receptors was also 
investigated. The study of the ErbB receptors in humans demonstrated that, in 
contrast to the present study, all of them were present in luteinized granulosa cells 
(72). The discrepancy is probably due to species specificity or the difference 
between using cultured granulosa cell and freshly isolated follicular layer. Since 
ErbB2 has no ligand-binding capacity (93), its presence on the follicular layer 
revealed in this study probably serves as a positive amplifier by forming 
heterodimer with ErbBl to enhance and prolong the output (176). In spite of the 
localization of erbbS and erbb4 on the oocyte, their expression levels were very low. 
The low expression level of erbb4 in the zebrafish ovary is consistent with the 
reports in chicken (134) whilst its expression is even absent in rat ovary (174). 
Besides, only BTC and HB-EGF have high affinity towards ErbB4 homodimer or 
ErbB3-ErbB4 heterodimer (163，164). Therefore, the high expression level of egfr 
(erbbl) and low levels of others in the ovary may suggest that the major ErbB 
receptor in the follicles for EGF ligands, especially EGF and TGFa, is likely EGFR. 
Together, the spatial distribution patterns of EGF ligands and receptors in the 
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zebrafish follicle strongly implicate potential roles of the EGF ligands as oocyte-
derived paracrine factors to signal the follicular layer. Together with the spatial 
i 
distribution of the activin family, the conspicuous contrast between the two families 
led us speculate that the two families of growth factors may constitute a regulatory 
loop which serves as communication bridge between the follicular layer and the 
oocyte (Fig. 2.13). Hence it is of interest to study whether these two families are 
subjected to regulation by each other. 
There is a discrepancy between our previous results and the present study 
on the spatial expression of the EGF family (141) and the activin family (177) 
within the ovarian follicle. For example, while we demonstrated that egf and fst 
(follistatin) were expressed exclusively on the oocyte in this study, our previous 
results showed a minor expression of the genes on the follicular layer as well. The 
discrepancy can be attributed to the different methods used since our previous 
method offered a higher chance of cross-contamination between the follicular layer 
and the oocyte. Besides, the lack of oocyte marker gdf9 at that time limited the 
possibility of checking follicular layer purity. 
All four ligands exhibited a progressive decrease from PV to FG stage. A 
decreasing trend of EGF from preantral to large antral follicle was also observed in 
the hamster (168) while in the human the TGFa in oocyte was maximal at 
primordial follicle and decreased in later stages (169). EGF and TGFa were 
effective in stimulating granulosa cell proliferation (173, 178) while TGFa was 
shown to mimic the effect of oocyte extract in stimulating granulosa cell 
proliferation (179). It is tempting to speculate that the EGF ligands may also act as 
oocyte-derived factors to stimulate granulosa cell proliferation in zebrafish. 
Therefore their expression levels are higher at PV, EV and MV stage at which the 
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oocyte dramatically increases its diameter and the granulosa cells are undergoing 
most intense proliferation. This hypothesis certainly needs confirmation from 
/ 
functional study as well as verification of the expression profile at protein level. In 
contrast to the ligands, egfr displayed a significant increase during folliculogenesis, 
particularly the surge from PG to PV stage, which marks the recruitment of follicles 
for entering the fast secondary growth phase, and from MV to FG stage, which 
prepares the follicles for the final maturation and ovulation. The increase of egfr 
during folliculogenesis is also evident in mammals. For instance, no or low 
expression of egfr was detected in primordial follicles of human (166), rat (170) and 
hamster (167) but its expression became high in antral and preovulatory follicles. 
The increase of egfr can properly be related to the gonadotropin level since there 
were a number of reports demonstrating that egfr expression or phosphorylation was 
stimulated by endogenous (167, 180) and exogenous (124, 127, 167) gonadotropins. 
Whether LH, FSH or both are responsible for regulating EGFR still remains 
ambiguous due to the discordant results provided by different studies but it is 
interesting to observe that the expression profile of egfr in the present study 
resembles the combination of the two gonadotropin receptors Ihcgr and fshr. Hence 
EGFR may be the potential target of gonadotropins to couple their signaling 
pathways to the EGF-EGFR system. 
It is well documented that maternal mRNAs in the oocyte not only guide 
the oocyte to undergo maturation but also regulate post-fertilization events before 
zygotic transcription is activated (181, 182). Thus in order to determine whether the 
EGF ligand transcripts in the oocyte are used in regulating folliculogenesis or 
reserved for early embryonic development, the mRNA levels of the EGF family 
during embryogenesis were examined. The expression of efla increased after the 
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shield stage, indicating the massive transcription of the zygotic mRNA. For EGF 
family ligands, the expression dropped significantly after fertilization to 
undetectable levels at the shield stage. It is obvious that they are maternal 
transcripts in the egg and persist at cleavage stages before activation of the 
embryonic genome at mid-blastula transition, which is determined to be at cell cycle 
10 in zebrafish (183). Though the maternal mRNAs for the ligands persisted after 
fertilization for certain time, the mRNA of egfr was nearly absent in the embryos 
immediately after fertilization. Therefore, without the expression of its receptor, the 
leftover of the ligand mRNAs probably serves no role in early embryogenesis. This 
provides supportive evidence that the presence of EGF ligand transcripts in the 
oocyte is probably related to folliculogenesis rather than embryogenesis. In contrast 
to the present study, there have been reports in mammals that both the EGF ligands 
and receptors, including EGFR and ErbB4, are present in early zygote (184-187). 
However, their functional role is often related to implantation (184, 185, 187, 188), 
making the difference between mammals and zebrafish reasonable. 
Since the profiling of the EGF family was done only at mRNA level, we 
cannot exclude the possibility that the maternal mRNA was translated to protein to 
aid embryo development. Hence in order to further assess the functional role of the 
EGF family during embryogenesis, tyrphostin AG 1478 was added to block the 
kinase activity of EGFR. Though 5 \xM of tyrphostin AG 1478 caused delayed 
development and aberrant morphology in the embryos, the effect did not appear 
until the shield stage, which correlates well with the expression of egfr mRNA from 
the embryonic genome from this stage. In addition, since tyrphostin AG 1478 has 
been proven effective in blocking also the kinase activity of ErbB4 (189), the 
possibility that the ligand maternal mRNAs carried over from the oocytes may be 
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translated and bind to ErbB4 in embryos was also eliminated. 
In summary, the present study demonstrated the expression of the EGF 
ligands in the oocyte and egfr in the follicular layer exclusively, supporting our 
previous hypothesis of EGF ligands being oocyte-derived paracrine factors to 
regulate follicular cell function. In addition, the increasing pattern of the egfr during 
folliculogenesis insinuated its potential relationship with pituitary gonadotropins. 
The EGF ligands may not be involved in early embryonic development owing to the 
absence of its receptor at that period. This further supports the involvement of the 
EGF family in pre-fertilization rather than post-fertilization events, i.e., 
folliculogenesis but not embryogenesis. 
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Figure 2.1 Optimization of cycle number for semi-quantitative RT-PCR for (A) 
btc, (B) tgfa and (C) hbegf. The values are the mean 土 SEM (n = 3). 
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Figure 2.2 Semi-quantitative RT-PCR on tissue distribution of the EGF ligand 
family. gdf9 was used as gonad-specific marker and thus expressed in testis and 
ovary only, egf was found to be predominantly expressed in the gonad while the 
expression of btc, tgfa and hbegf was nearly universal in all organ examined. G， 
gill; B, brain; M, muscle; L, liver; K, kidney; T, testis; 0，ovary; P, Pituitary; +, RT 
with reverse transcriptase; RT without reverse transcriptase. 
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Figure 2.3 Targets of the spatiotemporal distribution experiments. (A) Denuded 
oocyte and follicular layer. (B) Five stages of follicles and table showing the 
diameters of the follicles. (C) Seven stages of embryos and table showing the time 
of the embryos after fertilization. 
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Figure 2.4 Semi-quantitative RT-PCR on localization of the marker genes, the 
EGF and the activin family members in the follicular layer, oocyte and intact 
follicles. Clean separation was indicated by the dominant expression of Ihcgr and 
fshr in the follicular layer and gdJ9 in the oocyte. Among the EGF family, the 
ligands displayed dominant expression in the oocyte with an exception of minor btc 
expression in follicular cell. The expression of egfr was contrarily dominant in the 
follicular layers. For the activin family, its expression is in contrast to the EGF 
family as its ligand subunits showed dominant expression in the follicular layer 
while the receptors were predominantly expressed in the oocyte. Follistatin, the 
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Figure 2.5 Semi-quantitative RT-PCR on localization of other ErbB receptor 
family members in the follicular layer, oocyte and intact follicles. The expression of 
erbb2 was found only in the follicular layer while the expression of erbb4 and the 
two isoforms of erbb3 was localized to the oocyte. 
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Figure 2.6 Real-time RT-PCR quantification of temporal expression patterns of 
Ihcgr, fshr and egfr during folliculogenesis. The expression of Ihcgr (A) increased 
slowly during folliculogenesis and with an obvious surge from MV to FG follicle. 
fshr (B) expression increased progressively and peaked at MV follicle followed by a 
drop at FG follicle. The expression of egfr (C) showed two increases during 
folliculogenesis, one from PG to PV while the other from MV to FG. It is noted that 
the expression profile of egfr resembles the combination of the two gonadotropin 
receptors. The relative mRNA levels after normalization to the housekeeping gene 
efla are represented by the bar charts (i) and the ones without normalization are 
represented by the line charts (ii). The values are the mean 土 SEM (n = 3) from a 
representative experiment. Different letters indicate statistical significance (P < 0.05). 
PG, primary growth; PV, previtellogenic stage; EV, early vitellogenic stage; MV, 
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Figure 2.7 Real-time RT-PCR quantification of temporal expression patterns of 
egf, tgfa, hbegf and btc during folliculogenesis. The expression of egf and tgfa 
displayed a more apparent change during folliculogenesis than hbegf and btc did. 
The values are the mean 土 SEM (n = 3) from a representative experiment. PG, 
primary growth; PV, previtellogenic stage; EV, early vitellogenic stage; MV, 


























































































































































































Figure 2.8 Real-time RT-PCR quantification of temporal expression patterns of 
egf, tgfa, hbegf and btc during folliculogenesis. egf (A) and tgfa (B) expression both 
increase from PG to PV follicle and later decreased at FG stage. Expression of hbegf 
(C) was relatively stable whereas btc (D) displayed a decrease during 
folliculogenesis. The relative mRNA levels after normalization to the housekeeping 
gene efla are represented by the bar charts (i) and the ones without normalization are 
represented by the line charts (ii). The values are the mean 土 SEM (n = 3) from a 
representative experiment. Different letters indicate statistical significance (P < 0.05). 
PG, primary growth; PV, previtellogenic stage; EV, early vitellogenic stage; MV, 
midvitellogenic stage; FG, full-grown. 
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Figure 2.9 Real-time RT-PCR quantification of temporal expression patterns of 
egfr, egf, tgfa hbegf and btc during folliculogenesis. The bar charts represented the 
relative mRNA levels after normalization to the housekeeping gene efla but not 
normalized to PG. The relative abundance of different genes can be compared by the 
value of the y-axis. It was found that btc (E) was the gene with strongest expression 
followed by hbegf (D) and tgfa (C). egfr (A) expression was relatively weak and egf 
(B) was the most weakly expressed gene. The values are the mean 土 SEM (n = 3) 
from a representative experiment. PG, primary growth; PV, previtellogenic stage; 
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Figure 2.10 Real-time RT-PCR quantification of temporal expression patterns of 
efla and egfr during embryogenesis. The expression of efla (A) increased since the 
shield stage indicating the massive transcription of embryonic genome. The 
expression of egfr (B) remained low and increased after the bud stage. For egfr, the 
relative mRNA levels after normalization to the housekeeping gene efla are 
represented by the line charts (i) and the ones without normalization are represented 
by the line charts (ii). The values are the mean 土 SEM (n = 3-4) from a 


















































































































































































































































Figure 2.11 Real-time RT-PCR quantification of temporal expression pattern of 
(A) egf, (B) tgfa, (C) hbegf and (D) btc during embryogenesis. For all four ligands, 
the leftover of the maternal mRNA remained after fertilization and completely shut 
down at the shield stage. The relative mRNA levels after normalization to the 
housekeeping gene efla are represented by the line charts (i) and the ones without 
normalization are represented by the line charts (ii). The values are the mean 土 
SEM (n = 3 ^ ) from a representative experiment. Different letters indicate 
statistical significance (P < 0.05). 
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Figure 2.12 Developing embryos in the absence or presence of the EGFR kinase 
inhibitor tyrphostin AG 1478 (5 |iM) at different incubation times. The drug-treated 
embryo remained morphologically normal until 7.5 h after fertilization. Delayed or 
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Figure 2.13 Schematic representation of the spatial distribution of the EGF 
family and the activin family in the follicular layer and oocyte. Due to the exactly 
contrast expression of the two families, a hypothetical regulatory loop is proposed 
between them. It is hypothesized that the binding of oocyte-derived EGF ligand to 
its receptor EGFR on the follicular cell would trigger downstream pathway that 
affect the activin ligand subunits, which then bind to their receptor on the oocyte and 
in turn regulating the EGF ligands there. 
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Chapter 3 
Regulation of the EGF Family in Cultured Follicle Cells and 
Their Effects on the Expression of Activin Subunits 
3.1 Introduction 
Since the discovery of local production of TGFa in rat ovarian theca and 
interstitial cells (121), the studies of reproductive role of the EGF family have not 
only focused on the functionality of EGF ligands but also the regulation of the 
ovarian EGF system. However, majority of the studies has concentrated on 
hormonal regulation of the ovarian EGF ligands by pituitary gonadotropins (131， 
132, 135, 136), especially after they were suggested as the downstream mediators of 
gonadotropins by Park et al. (124). By comparison, relatively limited information 
about the paracrine or autocrine regulation of EGF family in the ovary is available. 
In humans, it was found that prostaglandin stimulated amphiregulin (AREG) and 
epiregulin (EREG) biosynthesis in granulosa cells via cAMP/PKA and MAPK 
pathway. Prostaglandin also stimulates areg expression in cumulus cells, suggesting 
that prostaglandin is regulating these two EGF ligands in both autocrine and 
paracrine manners (139). Another study in the mouse demonstrated that the oocyte-
derived growth factor BMP-15 induced the expression of areg, ereg, and btc in 
cumulus cells within 3 h (190). And when EGFR tyrosine kinase was blocked by 
inhibitor, the ability of BMP-15 to stimulate cumulus expansion was abolished. 
Taken together, the EGF system appears to be an important factor to mediate the 
action of BMP-15. There are then few other studies on the intraovarian regulation 
of EGF family, particularly in lower vertebrate such as teleosts. Thus the present 
study aimed at using zebrafish as a model, and the cultured follicle cell system 
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established by our laboratory (145), to investigate the regulation of the EGF family 
in teleost ovary. 
Besides, our laboratory has previously investigated the activin family in the 
zebrafish ovary and its role of stimulating oocyte maturation and mediating 
gonadotropin-induced oocyte maturation in vitro has been appreciated (157). Also, 
we have demonstrated the up-regulation of the inhba and inhbb expression by EGF 
in cultured follicle cells (141). Therefore we would like to go on to see the effects 
of other EGF ligands on cultured follicle cells to further scrutinize the relationship 
between the EGF and the activin family. Moreover, to further investigate to what 
extent the EGF family is essential in regulating/maintaining the expression of 
activin, a gene knockdown experiment targeting the EGF ligand was carried out by 
microinjecting morpholino antisense oligonucleotide into the oocyte. Morpholinos 
are synthetic nucleic acids that modify the backbone of natural nucleic acids but 
retain a high affinity for sense RNA sequences. The highly unnatural structure and 
the uncharged backbone make morpholinos extremely stable, non-degradable in 
biological systems and non-interactive with proteins to any significant extent (191, 
192). Thus morpholinos have emerged as an important tool for gene-specific 
knockdown. Zebrafish are a particularly good model for morpholinos-directed gene 
knockdown owing to the animal,s rapid external development and transparent 
embryos (193). Although most of the experiments involving morpholinos and 
zebrafish have been done on zebrafish embryos (194, 195), there are some 
successful reports on the microinjection of morpholinos into zebrafish follicles 
(196). Hence it appears that it is a promising method to investigate individual gene 
function using morpholinos in zebrafish follicles in the present study. 
In all, the regulation of the EGF family ligands and in turn their regulation 
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of the activin subunits in zebrafish follicles were investigated in the present study. It 
was hoped that these studies would further substantiate our previous hypothesis that 
the EGF ligands derived from the oocyte may serve as paracrine factors to regulate 
the somatic follicle cells. 
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3.2 Materials and Methods 
3.2.1 Chemicals 
/ 
All chemicals were obtained from Sigma-Aldrich (St. Louis, MO) unless 
otherwise specified. The human recombinant EGF, TGFa, BTC and HB-EGF were 
purchased from Pepro Tech (Rocky Hill, NJ). 
3.2.2 Primary Follicle Culture 
The follicles from about 20 female zebrafish were isolated with the full-
grown follicles removed by sieving. The follicles were washed with Medium 199 
(Gibco, Carlsbad, CA) for about five times and then cultured in Medium 199 
supplemented with 10% fetal bovine serum (Hyclone，Logan, Utah) at 28°C in 5% 
CO2 for 6 days to allow proliferation of follicle cells. The follicle cells were 
harvested by trypsinization and about 2.5 x 10^ cells were sub-cultured in each well 
of 24-well plates for 24 h. The cells were then starved with Medium 199 without 
serum for 12 h before treatment. 
3.2.3 Ovarian Fragment Incubation 
The zebrafish were anesthetized with ethyl 3-aminobenzoate 
methane sulfonate (MS-222) or ice shock and decapitated before dissection. The 
ovaries from 15 zebrafish were carefully isolated and put in Cortland's medium. 
The ovaries were briefly dispersed, washed for a few times and distributed to the 
well of a 24-well plate for drug treatment in Cortland's medium with 0.1% glucose. 
3.2.4 Total RNA Isolation and Reverse Transcription 
Total RNA samples were isolated from the full-grown follicles, ovarian 
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fragments and cultured follicle cells, and reverse transcription was preformed as 
described in 2.2.7 of Chapter 2. , 
3.2.5 Semi-quantitative and Real-time Polymerase Chain Reaction (PGR) 
Semi-quantitative and real-time PGR were performed as described in 2.2.8 
of Chapter 2. The sequences of primers used are listed in Table 3.1 and the primers 
for semi-quantitative and real-time PGR were identical unless otherwise specified. 
3.2.6 Microinjection 
About two hundred FG follicles with diameter 600 \im were isolated, 
separated into three groups and put in Cortland's medium. Injection volume of the 
glass capillary (World Precision Instruments, Sarasota, Florida) was estimated by 
injecting oil droplet in medium using nanoliter injector A203XVB (World Precision 
Instruments) and measuring the diameter of the droplet. The follicles were injected 
with around 1 nl of 2 mM missense morpholino (5'-
CCTCTTACCTCAGTTACAATTTATA - 3，）or anti-EGF morpholino (5'-
CGGTCCCCTCCATCGAGGTTCATTC - 3，）(Gene Tools, LLC, Philomath, OR) 
which was designed by the on-line program from the manufacturer. The injection 
volume approximately equaled to 1% of the follicle volume and made up a final 
concentration of about 20 \xM inside the follicles. The follicles were incubated at 
28°C for 4 h and five healthy follicles were transferred in Tri-reagent for RNA 
extraction. 
3.2.7 Data analysis 
All the experiments were performed at least twice to confirm the results. 
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Then the data from one individual experiment were chosen to represent the result 
and the replicate number in each experiment was symbolize by "n" in the legend of 
figures. The mRNA level of each target gene was first normalized to the 
housekeeping gene efla and then expressed as percentage of the control group. All 
values were expressed as mean 土 SEM For some of the graphs, the result were 
plotted in two graphs such that one graph was normalized to the housekeeping gene 
efla whereas the other one was not. The graph without normalization served to 
prove that the change of the expression was due to the change of target gene but not 
that of the housekeeping gene. Statistical analysis was carried out by the GraphPad 
Prism 5 for Mac OS X (Graphpad Software, San Diego, CA). For experiments with 
two groups of samples, unpaired t test with 95% confidence intervals were used to 
compare the treatment group to the control group. For experiments with more than 
two groups of samples, One-way ANO\ A followed by Dunnett's test was used to 
compare all groups to the control group. 
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3.3 Results 
3.3.1 Expression of the EGF Family in Cultured Follicle Cells 
Despite the absence of egf, tgfa and hbegf expression in freshly isolated 
follicular layer, all of them were expressed in cultured follicle cells together with btc 
(Fig. 3.1). As expected, egfr transcript also appeared in cultured follicle cells with a 
strong expression comparable to 3 |ig of whole ovary RNA. As an oocyte-specific 
growth factor, gdf9 was used as a control to prove that the cultured follicle cells 
were not contaminated by PG follicle. 
3.3.2 Effects of EGF on the EGF Family Expression in Cultured Follicle Cells 
The administration of 20 nM recombinant human EGF to cultured follicle 
cells did not cause any significant change in egfr and egf expression in an 8-h time 
course (Fig. 3.2 A and B). But EGF regulated the expression of btc and hbegf in 
opposite ways. It down-regulated the expression of btc to nearly half as early as 2 h 
after treatment (Fig. 3.2 C) and, on the contrary, up-regulated hbegf expression with 
the maximal 3-fold effect achieved at 4 h (Fig. 3.2 D). 
3.3.3 Effects of BTC and HB-EGF on the Expression of EGF Ligands in 
Cultured Follicle Cells 
Since EGF was effective in regulating both btc and hbegf expression, we 
then tested whether other EGF ligands could also exert similar effects. A 4-h time 
point which gave the maximum effect was chosen from the last experiment and a 
dosage response experiment was carried out. BTC and HB-EGF did not change the 
expression of egf significantly (Fig. 3.3 A and 3.4 A). Similar to the effects of EGF, 
BTC and HB-EGF suppressed the expression of btc (Fig. 3.3 B and 3.4 B) but 
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stimulated that of hbegf in a dose-dependent manner (Fig. 3.3 C and 3.4 C). 
/ 
3.3.4 Effect of EGF ligands on the Expression of Activin Subunits in Cultured 
Follicle Cells 
To elucidate the relationship between the EGF family and the activin 
family, four EGF ligands were administrated on cultured follicle cells to see their 
effects on the expression of activin subunits, inhba (PA) and inhbb ((3B), which are 
both exclusively expressed in the follicle cells. All the four ligands, namely EGF, 
TGFa, BTC and HB-EGF, were effective in stimulating the expression of inhba and 
inhbb but with a slightly different potency at the same dosage (Fig. 3.5). 
3.3.5 Effects of Actinomycin D on Ovarian Fragments 
To examine the stability and turnover rate of mRNAs in follicles, the 
ovarian fragments were incubated in the presence of actinomycin D (1 jag/ml) for 24 
h to block the de novo transcription of mRNA. The control group was also 
incubated for 24 h but without drug treatment. Semi-quantitative RT-PCR revealed 
that the expressions of EGF ligands including egf, tgfa, btc and hbegf were not 
altered by the actinomycin D (Fig. 3.6) as compared to the control. The expressions 
of other genes like fshr, egfr, inhba and inhbb were dramatically reduced by 
actinomycin D treatment (Fig. 3.7), suggesting the drug was effective in blocking 
transcription. 
3.3.6 Effects of Microinjecting Anti-EGF Morpholino on Full Grown Follicles 
A gene knockdown experiment targeting EGF mRNA was carried out by 
microinjecting anti-EGF morpholino into full-grown follicles. Follicles 
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micro injected with missense morpholino were used as the control to ensure that the 
effect caused by anti-EGF morpholino was due to specific knockdown of the target 
gene but not the microinjection step. 
As seen from the gel photo, there was a slight decrease of the inhba 
expression after microinjecting anti-EGF morpholino as compared to the control 
injected with missense morpholino (Fig. 3.8 A). But the decrease was not 
statistically significant. For inhbb, the expression is similar when injected with 
missense or anti-EGF morpholino. However, there is a peculiar 3- to 4-fold increase 
of the inhbb expression after microinjection (Fig. 3.8 B). 
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3.4 Discussion 
Surprisingly, the cultured follicle cells not only expressed btc, but also egf, 
/ 
tgfa and hbegf which were absent in freshly isolated follicular layer as demonstrated 
in the spatial distribution experiment. The following reasons are proposed to 
account for the discrepancy. First, the samples for the spatial distribution 
experiment consisted of only five follicular layers. The total mRNA amount in the 
sample may be far less than that in cultured follicle cells and thus the latter may 
express genes whose expression is extremely weak or even undetectable in follicular 
layer. This hypothesis is supported by the comparison of the absolute mRNA level 
of different EGF ligands normalized to efla during folliculogenesis. As seen from 
Fig. 2.8, btc is the ligands with the strongest expression. Its expression in full-
grown follicle is 5 to 6 times higher than that of other ligands and this may be the 
reason why only its expression could be detected in follicular layer. Second, the in 
vitro culture system may pose an effect on the expression of genes. For example, 
the study on cultured fetal human vascular smooth muscle cells showed that the 
addition of fresh 10% fetal calf serum to the cells led to a 12- to 14-folds rise of 
hbegf mRNA levels (197). Though the increase is only transient and we included a 
starvation period with serum-free medium before drug treatment in the protocol, the 
possibility that the EGF ligands' expression was stimulated by factors existing in 
fetal bovine serum should not be overlooked. Third, the follicles we chose for 
spatial experiment were the full-grown follicles while those used for follicle cell 
culture were the younger stage follicles. Hence there exists a possibility that the 
ligand genes are expressed only in follicular layer of younger stage follicles but not 
that of full-grown ones. There was a report in hamster that immunohistochemically 
stained EGF was most intense in granulosa cells of small preantral follicles but the 
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intensity declined during folliculogenesis and faded in large antral follicles (168). 
Similar decline was also observed for HB-EGF in rat preovulatory follicles (174). 
/ 
Thus extending the spatial distribution experiment to zebrafish follicles of younger 
stages seems to be indispensable to obtain a more complete picture of spatial 
expression. 
As the EGF ligands are expressed in cultured follicle cells, we then went on 
to investigate how these ligands are regulated by different factors. As the 
expression of tgfa was too low and close to the threshold detection level of real-time 
PCR, it was not included in the quantitative study. A consistent down-regulation of 
btc and up-regulation of hbegf was recorded when EGF, BTC or HB-EGF was 
added to follicle cells. This suggests that EGF ligands, which are properly derived 
from the oocyte, are exerting their influence on its neighbor follicular cells partly by 
influencing the expression of its own family members there. A similar result was 
recently observed in chicken in which the hbegf expression in cultured granulosa 
cells could be strongly induced by HB-EGF, EGF and TGFa (134). This auto-
induction and cross-induction within the EGF family is not unprecedented and was 
first demonstrated by the auto-induction of TGFa in keratinocytes (198). A study 
on the extensive auto-induction and cross-induction within the EGF family also 
proved the effect of EGF, TGFa, HB-EGF and AREG in stimulating the increase of 
tgfa, hbegf, areg and btc transcripts in human nontransformed intestinal epithelial 
line (199). It is hypothesized that this kind of induction is a mechanism by which an 
initial growth factor signal is amplified and sustained. More importantly, the 
potency of different ligands appeared similar in the experiment but the response of 
ligands differed with hbegf and areg being most rapidly induced and to a relatively 
greater extent (199). This may reflect different induction mechanisms for different 
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genes which may also attribute to the differential regulation of btc and hbegf m the 
present study. Nonetheless, to us a more interesting question than how the two 
i 
genes are differentially regulated is why the two genes are differentially regulated. 
Although both BTC and HB-EGF bind ErbBl and ErbB4, the two ligands actually 
displayed various unique features which are not shown by each other (60). One of 
these features is the extensive juxtacrine activity shown by the HB-EGF 
transmembrane precursor (200, 201). Besides, the cleavage of the HB-EGF 
transmembrane precursor from the membrane is also involved in EGFR 
transactivation by G-protein-coupled receptors (202). For BTC, it is the only ligand 
which binds all the possible combinations of ErbB heterodimers (163). Though the 
downstream events of BTC and HB-EGF in follicle cell are still not known, they 
may involve different patterns of receptor tyrosine phosphorylation, recruitment of 
different intracellular signaling proteins to the activated receptor and use of different 
signaling cascades (47), leading to different functions. On the other hand, we 
cannot rule out the possibility that the functions of BTC and HBEGF are indeed 
identical, but by differentially regulating their expressions the intrafollicular EGF 
system is fine-tuned by itself. In any way, in view of the cross-induction of the EGF 
family members, it should be cautious that the physiological role of any single 
ligand in vivo may need to be defined in terms of its interactive effects with other 
EGF ligands. 
Besides auto-regulation, we also demonstrated that EGF, TGFa, BTC and 
HB-EGF are all effective in stimulating the expression of both inhba and inhbb in 
cultured follicle cells. The regulation of follicular activin pA and |3B further 
supports the hypothesis that the oocyte-derived EGF ligands can modulate the 
functionality of follicular cells. In contrast to the present study, a study on bovine 
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granulosa cells showed that EGF alone had no stimulatory effect on activin A 
secretion but it abolished the effect of FSH-induced activin A secretion. EGF also 
promoted a modest increase in the activin A: inhibin A ratio in the same study (203). 
However, it is noteworthy that EGF was primarily localized to granulosa and theca 
cells in bovine ovary (204), thus it is not surprising that the interaction between EGF 
and activin is different between cattle and teleosts. A recent study on mouse 
cumulus-oocyte complex expansion also revealed a potential interaction between 
EGF and activin. It was demonstrated in this study that when the activin receptor-
like kinase 4/5/7 was blocked by inhibitor, the EGF-stimulated cumulus expansion 
was antagonized (205). Together with the previous finding that EGF activates the 
MAPK3/1 and MAPK 14 pathway in cumulus cells (206), Dragovic et al. proposed 
that the member of transforming growth factor |3, including the activins, are oocyte-
derived factors which signal through the SMAD 2/3 pathway to enable EGF 
activation of MAPK. Thus though we managed to show the activation of inhba and 
inhbb expression by EGF ligands, the interaction between their downstream 
pathways also deserves consideration in order to completely dissect the relationship 
between the EGF family and the activin family. Studies on the direct interaction 
between the EGF family and the activins in mammalian ovary are rare, let alone the 
study in teleosts. It appears that our previous report of EGF stimulatory effect on 
inhba and inhbb expression in zebrafish ovary was the first in teleosts (141), and the 
present study further broadens the picture to other EGF ligands. 
Although the previous experiment and the present study demonstrated the 
stimulatory effect of the EGF ligands on activin subunit expression, they were 
carried out using in vitro follicle cell culture system and the EGF ligands added 
were exogenous. To what extent this result reflects the in vivo situation is a question 
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that should never be disregarded. Therefore, in order to prove that the endogenous 
oocyte-derived EGF ligand also exerts similar stimulatory effect on activin subunit 
/ 
expression, a gene knockdown experiment was carried out by using antisense 
moipholino oligonucleotide to specifically block the production of oocyte-derived 
EGF ligand protein. 
Prior to the microinjection experiment, an experiment utilizing actinomycin 
D to block transcription was done to provide clue for the sequence design of the 
moipholino. The expression level of mRNA inside the follicle depends on both the 
transcriptional rate and stability of the mRNA. In the present study, when the 
transcription of mRNA in ovarian fragments was inhibited for 24 h by actinomycin 
D, which binds the DNA at the transcription initiation complex and prevents 
elongation by RNA polymerase, no significant change was observed in the 
expression of egf, tgfa, btc and hbegf as compared to the control. This shows that 
there is little de novo transcription of the EGF ligands' mRNA during the 24-h time 
course and thus probably implicates a low turnover rate of the mRNA. And 
interestingly, the expression of oocyte-derived genes could not be blocked by 
actinomycin treatment (Fig. 3.6) while all the follicular layer-derived genes could be 
blocked (Fig. 3.7). This result may implicate a generally higher turnover rate of the 
mRNA transcripts in the follicular layer than those in the oocyte. Morpholinos can 
be designed to block either translation, by binding to the translational start site AUG 
of post-spliced mRNA, or to block nuclear processing events, by targeting an intron-
exon boundary to cause exon deletion (195). As suggested by the actinomycin D 
experiment, the turnover rate of the EGF mRNA is low and thereby the antisense 
morpholino that specifically blocks the splicing of immature mRNA may exert little 
effect on the production of EGF protein. Therefore, an antisense morpholino that 
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blocks the initiation of translation was designed and synthesized. 
Preliminary result from the microinjection experiment revealed a down-
regulation of the inhba expression, though insignificant, by anti-EGF morpholino. 
The same expression patterns were repeated for several times in independent 
experiments (data not shown). This result implied that the oocyte-derived EGF 
might be effective in up-regulating inhba expression or maintaining its basal 
expression. However, the loss of EGF could be compensated by other EGF ligands. 
This redundancy is suggested by our previous experiment that the four EGF ligands 
were all effective in promoting inhba expression. Consistent with the redundancy of 
the system, there are numerous studies in mammals that the knockout mice null for a 
single or several EGF ligands were normal or had mild abnormal phenotypes (76, 
207), which are incomparable to the severe damaging or even lethal effect caused by 
egfr knockout (208, 209). Therefore, in our case, it may not be enough to study 
individual gene function by single knockdown in zebrafish follicle; instead, the 
simultaneous knockdown of multiple EGF ligands may be preferable to investigate 
the integrated functions of EGF family ligands. 
An interesting yet strange observation in this experiment is the increased 
level of inhbb expression after microinjection, no matter whether anti-EGF or 
missense morpholino was injected. There have been reports that, in ovarian 
carcinoma cell line, activins may have cell survival function and its protein level 
was increased after exposure to stress like heat shock (210). Hence the stimulation 
of inhbb expression may possibly be caused by the detrimental or stressful 
procedure of microinjection and introduction of exogenous substance into the 
follicles. 
In summary, the present study demonstrated the expression of all four EGF 
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ligands tested in cultured zebrafish follicle cells. Auto-regulation and cross-
regulation were observed within the EGF family in cultured follicle cells such that 
btc was down-regulated and hbegf was up-regulated by itself and other ligands. 
Besides, the EGF ligands were also effective in stimulating the expression of inhba 
and inhbb in cultured follicle cells. Altogether, it is hypothesized that the oocyte-
derived EGF ligands exert regulatory effects on the somatic follicular cell by 
influencing the expression levels of multiple genes there (Fig. 3.9). Probably due to 
the redundancy of the EGF ligands, the single knockdown of one EGF ligand was 
not effective in demonstrating its effect and multiple knockdown using a cocktail of 
morpholinos is recommended. 
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Table 3.1 Primers used for RT-PCR. Semi, semi-quantitative PCR; Real, real-
time PCR. 
Gene Accession no. No. Sequence Expected Cycle no. 
size (bp) used 
“ : " T T T T I Z r 692 5'- ATGGAATCACGGCTGCTCTCTGGGA - 3 ' " " “ ~ " ‘ 
egf NM 205731 304 32 
693 5’- GCATTCACAAACCCACCGGCCTGGA - 3， 
524 5'- AATCTAAAGCAGCACGGAGGTC - 3, 
btc BC 075954 456 30 
525 5，- GCAAATGAAAACGATGAGCAGAATC - 3’ 
686 5'- GACTGGAGAAGAACGGGCGAC - 3’ 
hbegf BQ 132224 294 32 
“ 687 5'- TACATTCCCAACCCTGAAGAGTTCC - 3' 
688 5，- CCGACTCCCACAGCCACTTC - 3’ 
t咖 AL 732598 ^^^ 5，-CAGCAGGATGTCCCACTCGTC - 3， ：^、 ^^ 
273 5'- ACCTGCAACGGCCCTGGACCCGA - 3' 
egfr NM 194424 462 32 
况 274 5'- AGCCCCGGAGCCCAGCACTTTGA - 3’ 
728 5'- GGCTGACTGTGCTGTGCTGATTG - 3, 
efla NM 131263 409 24 
729 5'- CTTGTCGGTGGGACGGCTAGG - 3’ 
iyjLu^ 694 5'- TGCTGCAAGCGACAATTTTA - 3' 
NM 130916 400 33 
(Semi) 153 5'- CATTCGTTTCGGGACTCAAG - 3' 
iyjj^hn 289 5’- CTACCGTATCCGAGGGTACAG - 3' 
NM 130916 149 N/A 
(Real) 290 5'- AGCCGCATTCTTCTACAATCAT - 3' 
iy^hhh 151 5'- CAACTTAGATGGACACGCTG - 3’ 
r X NM 131068 382 32 
(Semi) 152 5'- GTGGATGTCGAGGTCTTGTC - 3’ 
291 5'- ATGATGGAGAAACGTGTT - 3' , 
r , NM 131068 117 N/A 
(Real) 292 5'- GCAGTGGATGTCGAGGTCTT - 3’ 
206 5'- GAGTCTGTTGAACCCGACG - 3’ 
gdf9 NM 001012383 544 33 
b J 207 5'- GCAGGTGGATGTCCTTCTTA - 3’ 
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Cultured follicle cells Whole ovary 
(5x105cells) (3 mq RNA) 
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Figure 3.1 Semi-quantitative RT-PCR on gdf9, egfr and the four EGF ligands in 
cultured follicle cells and whole ovary. gdf9 was used as an oocyte-specific marker 
to prove that the cultured follicle cells were not contaminated by PG follicle. The 
expression of egfr and btc was found in cultured follicle cells as expected. But in 
contrast to their absence in freshly isolated follicular layer, egf, tgfa and hbegf were 
all expressed in cultured follicle cells. 
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Figure 3.2 Time course of recombinant human EGF (20 nM) effect on expression 
of egfr, egf, btc and hbegf in cultured follicle cells. EGF markedly suppressed the 
expression of btc (C) but induced that of hbegf (D) while the expression of egfr (A) 
and egf (B) was not affected by the administration of EGF. The relative mRNA 
levels after normalization to the housekeeping gene efla are represented by the bar 
charts (i) and the ones without normalization are represented by the line charts (ii). 
The values are the mean 土 SEM (n = 5) from a representative experiment. *, P < 
0.05; **,P<0.01 vs. control. 
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Figure 3.3 Dose response of recombinant human BTC effect on expression of (A) 
egf, (B) btc and (C) hbegf in cultured follicle cells for 4 h. Similar to the effect of 
EGF, BTC suppressed the expression of btc (B)，induced that of hbegf (C) and 
caused no effect on that of egf (A). The relative mRNA levels after normalization to 
the housekeeping gene efla are represented by the bar charts (i) and the ones 
without normalization are represented by the line charts (ii). The values are the 
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Figure 3.4 Dose response of recombinant human HB-EGF on expression of egf, 
btc and hbegf in cultured follicle cells for 4 h. Similar to the effects of EGF and 
BTC, HB-EGF differentially regulated the expression of btc and hbegf by down-
regulating the former (B) and up-regulating the latter (C). The expression of egf (A) 
was also not affected by HB-EGF. The relative mRNA levels after normalization to 
the housekeeping gene efla are represented by the bar charts (i) and the ones 
without normalization are represented by the line charts (ii). The values are the 
mean 土 SEM (n = 6) from a representative experiment. *, P < 0.05 vs. control. 
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Figure 3.5 Effects of different EGF family ligands on expression of inhba and 
inhbb in cultured follicle cells at 4 h. EGF, BTC, TGFa and HB-EGF were all 
effective in up-regulating the expression of inhba (A) and inhbb (B) to nearly two-
folds. The relative mRNA levels after normalization to the housekeeping gene efla 
are represented by the bar charts (i) and the ones without normalization are 
represented by the bar charts (ii). The values are the mean 土 SEM (n = 4 or 5) from 
a representative experiment. **, P < 0.01; ***, P < 0.001 vs. control. 
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Figure 3.6 Semi-quantitative RT-PCR quantification of the effect of actinomycin 
D (1 jAg/ml) on expression of (A) egf, (B) tgfa, (C) btc and (D) hbegf in ovarian 
fragments for 24 h. The expression of all four ligands was not significantly affected 
by blocking transcription indicating the low turnover rate of their mRNA transcript. 
The intensity of the bands in gel photos were quantified and the relative mRNA 
levels after normalization to the housekeeping gene efla are represented by the bar 
charts (i) and the ones without normalization are represented by the bar charts (ii). 
The values are the mean 土 SEM (n = 4) from a representative experiment. 
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Figure 3.7 Semi-quantitative RT-PCR quantification of the effect of actinomycin 
D (1 fxg/ml) on expression of (A) fshr, (B) egfr, (C) inhba and (D) inhbb in ovarian 
fragments for 24 h. The expression of the genes decreased markedly after 
transcription was blocked, implicating a high de novo synthesize rate of mRNA 
transcript in follicular layer. The intensity of the bands in gel photos were 
quantified and the relative mRNA levels after normalization to the housekeeping 
gene efla are represented by the bar charts (i) and the ones without normalization 
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Figure 3.8 Semi-quantitative RT-PCR quantification of inhba and inhbb 
expression after microinjection of anti-EGF morpholino into zebrafish full-grown 
follicles. After microinjection of anti-EGF morpholino, inhba expression (A) was 
suppressed but the suppression was not statistically significant. The expression of 
inhbb (B) was induced by both micro injecting missense and anti-EGF morpholino. 
The intensity of the bands in gel photos were quantified and the relative mRNA 
levels after normalization to the housekeeping gene efla are represented by the bar 
charts. The values are the mean 土 SEM (n = 3) from a representative experiment. 
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Figure 3.9 Hypothetical model on the regulation of follicular layer by the oocyte-
derived EGF family ligands. The oocyte-derived EGF family ligands modulated the 
function of somatic follicle cells by up-regulating the expression of hbegf and the 
two activin subunits but down-regulating that of btc. It is hypothesized that by 





The present study provides compelling evidence for the role of EGF 
ligands as paracrine factors from the oocyte to regulate the function of follicular 
cells in zebrafish ovary. Besides, another piece of important information provided 
by the present study is the relationship between the EGF family and the activin 
family in the ovarian follicle. The interaction between the two families presumably 
answers the unsolved question why EGF and TGFa could promote zebrafish oocyte 
maturation, as we previously demonstrated (145), without the expression of their 
receptor egfr in the oocyte. It appears that the answer lies in the activin family. The 
up-regulation of inhba and inhbh expression by the four EGF ligands demonstrated 
in the present study apparently put the activin downstream of the EGF ligands. 
Together with the exactly opposite spatial distribution patterns of the EGF family 
and the activin family, it is hypothesized that the oocyte-derived EGF ligands 
stimulate the expression of its downstream mediator activin which then returns back 
to signal the oocyte to promote oocyte maturation (Fig. 4.1). This hypothesis is 
further substantiated by our previous result that activin B could significantly 
increase the rate of oocyte maturation in vitro and both EGF- and activin B-induced 
oocyte maturation could be blocked by the activin binding protein follistatin (145, 
157). Another interesting question to address is whether EGF ligands are subjected 
to regulation by activin so that a regulatory loop exists between the two families, or 
in other words, between the follicular layer and the oocyte. 
In fact, the relationship between the EGF family and the activin family 
would never be completely appreciated unless their interaction with the pituitary 
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gonadotropins is considered. It is because apart from being regulated by the EGF 
ligands, activin is also subjected to regulation by gonadotropins. Our laboratory 
/ 
previously demonstrated that follistatin treatment significantly reduced the effect of 
human chorionic gonadotropin (hCG) on oocyte maturational competence (158), 
suggesting a role for activin as a downstream mediator of gonadotropins. Moreover, 
the two activin subunits are differentially regulated by the gonadotropins (211, 212). 
hCG stimulated inhba expression but inhibited inhbb expression in follicle cells. 
Thus it is of interest to investigate the interaction between the gonadotropins, the 
EGF family and the activin family. A possibility is that gonadotropins regulate the 
EGF family that in turn regulates the activin family. But if this is the case, a 
question exists as the inhbb expression is up-regulated by EGF ligands but down-
regulated by gonadotropin. To solve the puzzle, it appears that investigation on the 
regulation of the EGF family by gonadotropins is an ineluctable way to go. In 
mammals, amphiregulin and epiregulin have been well characterized to be the 
downstream mediators of gonadotropin at ovulation (124，127, 132, 135, 136, 213-
215), the regulation of other ligands and EGFR by gonadotropins still remains 
controversial. Some studies reported up-regulation of EGFR, EGF, TGFa and HB-
EGF by gonadotropin (167, 168, 174, 178) but others demonstrated that the ligands 
and receptors were irresponsive to the gonadotropin treatment (127, 138). Hence it 
is interesting to investigate the situation in other groups of vertebrates such as 
teleosts , which have never been examined so far. 
Moreover, due to the lack of suitable antibodies the present study was 
limited to mRNA expression level. The presence of transcript may not necessarily 
represent the translation of protein. Therefore one future direction of the present 
study, if it will be continued, should extend the investigation to protein level to 
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provide a more comprehensive picture. The study at protein level is particularly 
important for the EGF family owing to the transactivation of EGFR by G-protein-
coupled receptors (GPCR). It is well established that the binding of some ligands to 
their GPCR leads to intracellular stimulation of specific metalloproteinase, which 
then causes ectodomain shedding and release of soluble and bioactive EGF ligands 
extracellularly. The EGF ligands subsequently bind to EGFR to stimulate its 
phosphorylation and activation of intracellular MAPK signaling (202, 216, 217). 
This mechanism is often referred to as the "triple-membrane-passing-signaling" 
pathway as the signal crosses the cell membrane for three times (202). As seen in 
this model, the EGF ligands are not necessarily regulated by the GPCR 
transcriptionally but instead they can be regulated at the level of protein processing. 
Since the two gonadotropin receptors also belong to the GPCR superfamily, a 
possibility exists that the EGF ligands may be regulated by gonadotropins through 
proteolytic cleavage of the pre-existing ligand precursors and thereby investigation 
on only transcriptional level would probably overlook the entire picture. A recent 
study in the mouse demonstrated a dramatic up-regulation of the metalloproteinase 
ADAMS by hCG in granulosa cells of small follicles，further supporting that 
gonadotropin probably regulates the EGF family at multiple levels (218). 
In addition, to our knowledge, the involvement of BTC and HB-EGF in 
reproduction has never been investigated in teleosts. Indeed, the information on 
their reproductive roles in higher vertebrates is also relatively limited. BTC has 
been implicated in mouse oocyte maturation and cumulus expansion (124) and a 
recent study showed that overexpressing BTC in the mouse ovary reduced the litter 
size by impairing fertilization (133). The situation for HB-EGF is rather special 
because an in vitro study showed that the shedded and membrane-anchored forms of 
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HB-EGF displayed opposing roles by inhibiting or enhancing apoptosis of human 
luteinized granulosa cells respectively (72). The similar but not identical temporal 
expression patterns of different ligands during folliculogenesis (Fig. 2.7) 
demonstrated in the present study suggest that different ligands of EGF family 
possibly serve differential functions or subjected to differential regulation in 
zebrafish ovary. This issue deserves further investigation. 
In summary, the spatial localization of the EGF family provides primary 
evidence that EGF ligands may act mainly as the oocyte-derived paracrine factors to 
regulate the function of follicular cells. The regulation of the EGF ligand and 
activin subunit expression by different ligands of EGF family in cultured follicle 
cells further substantiates this hypothesis. Together with the studies in other 
species, especially those in mammals, the present study further points to EGF 
network in the ovary as a potential bridge or link between endocrine signals and 
various paracrine, juxtacrine and autocrine signals from local ovarian steroids and 
growth factors. Therefore the present study is just the tip of the iceberg of the EGF 
network in the ovary. Using our well-established system in the zebrafish, further 
study on the interaction between the EGF family and different molecules, 
particularly gonadotropins and activin, would definitely provide insight on the 
ovarian EGF network and hopefully help to fill the missing piece of the EGF story 
in vertebrate reproduction. 
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Figure 4.1 Schematic representation of the hypothetical regulation pathway of the 
EGF ligands on oocyte maturation competence. It is hypothesized that the binding of 
oocyte-derived EGF ligand to its receptor EGFR on the follicular cell would induce 
the expression of the two activin ligand subunits, which then bind to their receptor 
on the oocyte to stimulate oocyte maturation competence. 
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